检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李妤 张宇鸣 田丰 LI Yu;ZHANG Yuming;TIAN Feng(Shanghai Biomedical Industry Promotion Center,Shanghai 200125,China;Industrial Internet Innovation Center(Shanghai)Co.,Ltd.,Shanghai 201306,China)
机构地区:[1]上海市生物医药产业促进中心,上海200125 [2]工业互联网创新中心(上海)有限公司,上海201306
出 处:《上海医药》2022年第19期53-57,共5页Shanghai Medical & Pharmaceutical Journal
摘 要:当前各国政府均十分重视生物医药产业的发展,将其视为新的经济增长点。与发达国家及地区相比,我国生物医药产业尽管已取得了长足进步,但其发展时间短,基础相对薄弱,故提高生物医药产业核心竞争力和整体竞争实力刻不容缓。本文通过对部分生物医药产业竞争力评价指标体系汇总、梳理和解析,力图建立更加全面、合理的生物医药产业竞争力评价指标体系,不但希望可以帮助企业决策者制定合适的创新及发展策略;同时也希望能够为政府管理部门在制定相关引导政策时提供参考,共同促进生物医药产业的发展。Presently,governments of all countries attach great importance to the development of the biomedical industry and regard it as a new economic growth point.The biomedical industry in China has made great progress,however the time for its development is short and its foundation is also relatively weak compared with those in the developed countries and regions,so it is urgent to improve the core competitiveness and overall competitive strength of the biomedical industry.Based on other competitiveness evaluation indicator systems of biomedical industry research,this article seeks to establish a more comprehensive and reasonable competitiveness evaluation indicator system of the biomedical industry,in the hope of not only helping entrepreneurs to formulate appropriate innovation and development strategies,but also providing reference for the government administration in formulating relevant guiding policies to jointly promote the development of the biomedical industry.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.229